NRP1 and central nervous system cancer: CCK8 proliferation assay showed that NRP1 RNAi resulted in decreasing proliferation of C6 glioma cells treated with exogenous GDNF compared to C6 cells transduced with CON77 RNAi (Figure 8; P < 0.05).